# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hemophagocytic Lymphohistiocytosis (HLH)

Hemophagocytic lymphohistiocytosis
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 25 results.
Study to Evaluate Interferon Gamma (IFNγ) and Other Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis (M-HLH)
Status: Recruiting
Last Changed: Aug 13, 2019
First Received: Aug 23, 2017
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Blood Draws, Data Collection
Locations: University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)
Status: Recruiting
Last Changed: Feb 07, 2019
First Received: Dec 10, 2013
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): tocilizumab
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMICU)
Status: Recruiting
Last Changed: Sep 13, 2018
First Received: Apr 27, 2018
Disease(s): Hemophagocytic Lymphohistiocytosis
Locations: Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany
L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis
Status: Recruiting
Last Changed: Aug 04, 2016
First Received: Dec 16, 2015
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Pegaspargase, doxorubicin, etoposide, methylprednisolone
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
L-DEP as an Initial Treatment for EBV-HLH
Status: Recruiting
Last Changed: Sep 23, 2016
First Received: Sep 23, 2016
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Pegaspargase, doxorubicin hydrochloride liposome injection, etoposide, methylprednisolone, Etoposide, dexamethasone
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
Status: Not yet recruiting
Last Changed: Jun 13, 2019
First Received: Jun 13, 2019
Disease(s): Hemophagocytic Lymphohistiocytoses
Intervention(s): Emapalumab-Lzsg
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
MD Anderson Cancer Center, Houston, Texas, United States
Ruxolitinib Combined With Dexamethasone for HLH
Status: Recruiting
Last Changed: Jan 08, 2019
First Received: Jan 08, 2019
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Ruxolitinib, Dexamethasone
Locations: Yan Yue, Beijing, Chaoyang District, China
Yan Yue, Beijing, China
Etoposide in the First-line Treatment of Adult EBV-HLH
Status: Not yet recruiting
Last Changed: Nov 15, 2018
First Received: Nov 15, 2018
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): Etoposide, Dexamethasone, Etoposide, IVIG
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
DEP-Ru Regimen as a Salvage Therapy for HLH
Status: Recruiting
Last Changed: May 30, 2018
First Received: May 23, 2018
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): DEP-Ru
Locations: Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Status: Recruiting
Last Changed: Aug 09, 2019
First Received: Feb 24, 2014
Disease(s): Hemophagocytic Lymphohistiocytosis
Intervention(s): NI-0501
Locations: Children's Hospital Colorado, Aurora, Colorado, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Cincinnati Children's Hospital - Division of Immunobiology, Cincinnati, Ohio, United States
... and 17 other locations.